Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study.

Søby, Sebastian; Gothelf, Anita; Gyldenkerne, Niels; Bentzen, Jens; Nowicka-Matus, Kinga; Tramm, Trine; Eriksen, Jesper Grau

Søby, Sebastian; Gothelf, Anita; Gyldenkerne, Niels; Bentzen, Jens; Nowicka-Matus, Kinga; Tramm, Trine; Eriksen, Jesper Grau.

Afiliação

Søby S; Department Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Gothelf A; Department Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Gyldenkerne N; Department Oncology, Odense University Hospital, Odense, Denmark.
Bentzen J; Department Oncology, Herlev Hospital, Copenhagen, Denmark.
Nowicka-Matus K; Department Oncology, Aalborg University Hospital, Aalborg, Denmark.
Tramm T; Department Pathology, Aarhus University Hospital, Aarhus, Denmark.
Eriksen JG; Department Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Acta Oncol ; 61(8): 972-978, 2022 Aug.

Article em En | MEDLINE | ID: mdl-35913523

Assuntos

Neoplasias de Cabeça e Pescoço; Nivolumabe; Idoso; Estudos de Coortes; Neoplasias de Cabeça e Pescoço/tratamento farmacológico; Humanos; Recidiva Local de Neoplasia/tratamento farmacológico; Recidiva Local de Neoplasia/patologia; Carcinoma de Células Escamosas de Cabeça e Pescoço/tratamento farmacológico

Palavras-chave

Head and neck cancer; immunotherapy; national data; palliative treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nivolumabe / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google